Parabolan 200 - Canada Peptides

The history of Trenbolone enanthate reflects its unconventional path. Trenbolone itself originated in Roussel-UCLAF’s 1967 research, but only acetate forms reached veterinary medicine. The enanthate ester appeared much later, in 2004, when the underground company British Dragon launched Trenabol. Promoted as a long-acting injectable, it never achieved legitimate pharmaceutical approval. Nevertheless, Trenbolone enanthate established itself in the underground market as a potent derivative of nandrolone with enhanced anabolic-androgenic strength.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Parabolan 200 by Canada Peptides, consult with your doctor or healthcare professional.